Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AHEAD Medicine’s Cyto-copilot platform automates complex flow cytometry data analysis up to 100x faster than manual methods. It improves consistency, scalability, and reproducibility of results. The technology is being adopted by hospitals for leukemia diagnosis and has been recognized at international conferences. The company collaborates with NIST Flow Cytometry Standards Consortium to support cell and gene therapy applications.\nRecent clinical highlights include partnerships with Show-Chwan Cancer Hospital for AI-powered leukemia diagnosis; results have been published in reference textbooks ("教科書") in Taiwan.\nFDA submission planned by end of 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AHEAD Medicine.